Specific increase in enzymatic activity of adenosine deaminase 1 in rheumatoid synovial fibroblasts
- PMID: 12632419
- DOI: 10.1002/art.10956
Specific increase in enzymatic activity of adenosine deaminase 1 in rheumatoid synovial fibroblasts
Abstract
Objective: Adenosine deaminase (ADA; EC 3.5.4.4) activity is elevated in the synovial fluid (SF) of patients with rheumatoid arthritis (RA). Since the antiinflammatory effect of methotrexate is reportedly associated with increased levels of extracellular adenosine, the present study was undertaken to clarify the role of 2 ADA isozymes, ADA1 and ADA2, in the pathogenesis of RA.
Methods: The activities of ADA1 and ADA2 were measured in SF from RA and osteoarthritis (OA) patients, in sera from RA patients, and in lysates prepared from mononuclear and polymorphonuclear cells from SF from RA patients, peripheral blood from RA patients, and fibroblast-like synoviocytes (FLS) from RA and OA patients. Also measured were the effects of proinflammatory cytokines on ADA1 activity and ADA messenger RNA (mRNA) expression in RA FLS, as determined using real-time polymerase chain reaction. The adenosine concentration in RA SF was measured by radioimmunoassay.
Results: The adenosine concentration in RA SF ranged from 0.027 microM to 0.508 microM (mean +/- SD 0.156 +/- 0.132 microM). At those concentrations, ADA1 would be expected to be functionally dominant due to its higher affinity for adenosine. ADA1 activity in RA SF (mean +/- SD 14.4 +/- 8.5 IU/liter) was significantly higher than that in OA SF (3.0 +/- 1.1 IU/liter) or RA sera (3.0 +/- 0.6 IU/liter); moreover, ADA1 activity in RA FLS lysate was the highest among the cell lysates tested. Proinflammatory cytokines did not affect ADA1 activity or ADA mRNA expression in RA FLS.
Conclusion: Elevated ADA1 activity is an intrinsic characteristic of RA FLS, which likely contributes to the pathogenesis of RA by neutralizing the antirheumatic properties of endogenous adenosine.
Similar articles
-
Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis.J Rheumatol. 2005 Dec;32(12):2291-8. J Rheumatol. 2005. PMID: 16331752
-
[Aberrant over-expression of adenosine deaminase and its significance on rheumatoid arthritis].Rinsho Byori. 2005 Aug;53(8):741-8. Rinsho Byori. 2005. PMID: 16190361 Japanese.
-
Correlations between matrix metalloproteinase-9 and adenosine deaminase isozymes in synovial fluid from patients with rheumatoid arthritis.J Rheumatol. 2001 Mar;28(3):485-9. J Rheumatol. 2001. PMID: 11296946
-
[Adenosine deaminase: isoenzymes ADA1 and ADA2].Pol Merkur Lekarski. 1997 Dec;3(18):288-90. Pol Merkur Lekarski. 1997. PMID: 9523470 Review. Polish.
-
[Adenosine deaminase].Nihon Rinsho. 1995 May;53(5):1178-83. Nihon Rinsho. 1995. PMID: 7602776 Review. Japanese.
Cited by
-
Exosomes derived from synovial fibroblasts from patients with rheumatoid arthritis promote macrophage migration that can be suppressed by miR-124-3p.Heliyon. 2023 Mar 30;9(4):e14986. doi: 10.1016/j.heliyon.2023.e14986. eCollection 2023 Apr. Heliyon. 2023. PMID: 37151687 Free PMC article.
-
Anti-Inflammatory Effects of Endogenously Released Adenosine in Synovial Cells of Osteoarthritis and Rheumatoid Arthritis Patients.Int J Mol Sci. 2021 Aug 19;22(16):8956. doi: 10.3390/ijms22168956. Int J Mol Sci. 2021. PMID: 34445661 Free PMC article.
-
Biochemical characterization of adenosine deaminase (CD26; EC 3.5.4.4) activity in human lymphocyte-rich peripheral blood mononuclear cells.Braz J Med Biol Res. 2021 May 24;54(8):e10850. doi: 10.1590/1414-431X2020e10850. eCollection 2021. Braz J Med Biol Res. 2021. PMID: 34037096 Free PMC article.
-
Purinergic System Signaling in Metainflammation-Associated Osteoarthritis.Front Med (Lausanne). 2020 Aug 28;7:506. doi: 10.3389/fmed.2020.00506. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32984382 Free PMC article. Review.
-
The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.Pharmacol Rev. 2019 Jul;71(3):345-382. doi: 10.1124/pr.117.014878. Pharmacol Rev. 2019. PMID: 31235653 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials